Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD

ClinicalTrials.gov ID: NCT00536016

Public ClinicalTrials.gov record NCT00536016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 8:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Open Label Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of Single and Repeated Doses of JSM6427 Following Administration by Intravitreal Injection in Patients With Neovascular AMD

Study identification

NCT ID
NCT00536016
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Jerini Ophthalmic
Industry
Enrollment
36 participants

Conditions and interventions

Interventions

  • JSM6427 Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2007
Primary completion
Nov 30, 2008
Completion
Nov 30, 2009
Last update posted
Sep 20, 2010

2007 – 2009

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Retina Vitreous Associates Medical Group Beverly Hills California 90211
Ophthalmic Consultants of Boston Boston Massachusetts 02114
William Beaumont Research Institute Royal Oak Michigan 40873
Dean McGee Eye Institute Oklahoma City Oklahoma 73120
Palmetto Retina Center West Columbia South Carolina 29169
Black Hills Regional Eye Institute Rapid City South Dakota 57701
Retina Research Institute of Texas Abilene Texas 79606
Vitreoretinal Consultants Houston Texas 77030
Valley Retina Institute McAllen Texas 78503

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00536016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 20, 2010 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00536016 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →